BIO benefits from supply tightening driven by AI-powered DeSci application acceleration and protocol upgrades, with market sentiment and functional value significantly improved. The current price remains above the strong support at 0.03217; if it breaks through the resistance at 0.0348, it is expected to further test the 0.0372/0.0384 range and could open the upward channel towards 0.04812. Investment advice: Maintain a phase-biased bullish allocation, pay attention to breakout signals under price-volume resonance, and control positions with laddered, batch layouts based on resistance levels.

A recent demonstration using AI systems to design ADHD peptide drug candidates within 24 hours significantly shortened R&D cycles and considerably reduced costs, highlighting the protocol's innovative capabilities in the decentralized science field. This favorable news stimulated investor imagination regarding token application scenarios, driving a rapid price surge after the announcement, accompanied by markedly increased trading activity, forming a clear short-term positive sentiment.

Bio Protocol's native token $BIO surged due to hype around its AI-driven decentralized science (DeSci) efforts, notably designing an ADHD peptide drug candidate in 24 hours for under $1,500 using their AI system PeptAI. This breakthrough highlights AI's role in reducing drug discovery costs, enabling community-funded research on neglected diseases. Despite challenges like data access and clinical trials, strong trading volume and independent price growth indicate solid investor interest in $BIO.

Bio Protocol Gains Momentum as AI-Driven DeSci Hype Builds

The protocol’s upgraded BioXP minting and Ignition selling mechanisms allow users to burn BIO to mint BioXP and lock USDC to receive allocation shares, effectively decreasing the total circulating supply of BIO and injecting new motivation for holders to participate in the upcoming financing round. This move may create a temporary supply-side tightening effect while endowing the token with new value vectors, helping stabilize medium- to long-term market expectations.

Bio Protocol has launched an upgrade to BioXP and opened the Ignition sale for users holding USDC. Users can mint BioXP by burning BIO tokens, which will determine allocation shares if oversubscribed. The sale offers full refunds if targets aren't met, allocations based on USDC contributions if met, and priority for those pairing USDC with BioXP during oversubscription. Remaining USDC will be proportionally allocated or refunded.

Bio Protocol launches BioXP upgrade; Ignition sale is now open

From the daily chart perspective, BIO has gained support at the 0.03217 mark and is trending upwards with recent trading volume increasing nearly sevenfold, indicating significantly rising market attention and buying willingness. Daily upper wick pullbacks show selling pressure, but aggressive buying during corrections suggests strong demand; if the price successfully breaks above the 0.0348 resistance, it will further test the 0.0372/0.0384 zone, and maintaining above these would open space towards 0.04812. Overall, the technical bias remains bullish, with short-term focus on key resistance breakouts and volume cooperation.

Bio Unit 000

Iran seeks response to US naval blockade disrupting oil exports: WSJ

CNN report: Iranian strikes damage US bases, escalating tensions

Fed presidents oppose rate cuts, signaling hawkish stance for 2026

Jim Cramer warns of economic decline amid rising US inflation

Fed Pumps $8.26B Into Markets Overnight, Is Something Bigger Unfolding?

Federal Reserve's Logan should not imply easing policy guidance.

The Federal Reserve's Kashkari and Harker stated that the conflict has changed the interest rate outlook, and maintaining an accommodative stance is no longer appropriate.

Global news you need to know before the US stock market opens on Friday.

Fed's Hammack: Uncertainty around economy, policy path has risen

Two Federal Reserve officials said they dissented over this week’s policy statement because it was no longer appropriate to signal the Fed’s next move was still likely to be an interest-rate cut.

Bybit-ge

რეალურ დროში დიაგრამა Bio Unit 000-დან USD-ში კონვერტაციისთვის. იხილეთ მიმდინარე BIO-დან USD-ში ფასები რეალურ დროში. კონვერტაცია, ყიდვა, გაყიდვა და ვაჭრობა Bio Unit 000-ზე Bybit-ge.

Bio Unit 000 ფასი: BIO დღევანდელი მიმდინარე ფასი | BIO საბაზრო კაპიტალიზაცია და გრაფიკის ანალიზი | Bybit-ge

current_price

price_change_24h

high_24h

low_24h

volume_24h

market_cap

circulating_supply

max_supply

ath_price

atl_price

BIO ფასი დღეს არის 0.00, ხოლო ფასის ცვლილება ბოლო 24 საათში — 0.89. გამოიყენეთ Convert-ი, იყიდეთ, გაყიდეთ და ივაჭრეთ BIO-ით Bybit-ge-ზე.

ადევნეთ თვალი Bio Unit 000-ის რეალურ ფასს, საბაზრო ლიმიტს, 24-საათიანი ვაჭრობის დიაპაზონს და რეალური დროის გრაფიკის მონაცემებს Bybit-ge-ზე.

Bio Unit 000 ფასი

ფასის სტატისტიკა

Bio Unit 000სიახლეები

ფასის ისტორია (USD)

Bio Unit 000 რესურსები

Bio Unit 000 ფასი

ფასის სტატისტიკა

Bio Unit 000სიახლეები

ფასის ისტორია (USD)

Bio Unit 000 რესურსები

სკანირება აპლიკაციის გადმოწერისთვის

გამოგვყევით სოციალურ მედიაში